8 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Bartels Legionella Urinary Antigen- an adjunct to culture for the presumptive diagnosis of past or current Legionnaire's Disease by qualitative detection of Legionella Pneumophila seragroup 1 antigen in human urine. Product Code: B1029-440

FDA Enforcement
Class II ·Terminated·Clark Laboratories, Inc.·December 22, 2021

Trinity Biotech Captia Measles IgM Kit, Catalog No. 2326060 - Product Usage: intended for the qualitative detection of Measles igM antibodies in human serum of patients suspected of measles (rubeola) infection.

FDA Enforcement
Class II ·Terminated·Clark Laboratories, Inc.·May 5, 2021

Genesys Diluent Reagent, REF 01-03-0019 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange chromatography. For in vitro diagnostic use only.

FDA Enforcement
Class II ·Terminated·Clark Laboratories, Inc. (dba,Trinity Biotech USA)·December 26, 2018

ultra2 Genesys Variants Analyzer, REF 03-01-0045 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange chromatography. For in vitro diagnostic use only.

FDA Enforcement
Class II ·Terminated·Clark Laboratories, Inc. (dba,Trinity Biotech USA)·December 26, 2018

Genesys Analytical Column, REF 01-05-0017 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange chromatography. For in vitro diagnostic use only.

FDA Enforcement
Class II ·Terminated·Clark Laboratories, Inc. (dba,Trinity Biotech USA)·December 26, 2018

Genesys 2 Reagent, REF 01-03-0022 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange chromatography. For in vitro diagnostic use only.

FDA Enforcement
Class II ·Terminated·Clark Laboratories, Inc. (dba,Trinity Biotech USA)·December 26, 2018

Genesys 1 Reagent, REF 01-03-0020 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange chromatography. For in vitro diagnostic use only.

FDA Enforcement
Class II ·Terminated·Clark Laboratories, Inc. (dba,Trinity Biotech USA)·December 26, 2018

Captia Syphilis-G Test Kit Product Usage: This is an enzyme immunoassay for the qualitative detection of IgG antibodies to T. pallidum in serum specimens, to be used in conjunction with non-treponemal testing to provide serological evidence of infection with T. pallidum ( the agent of syphilis). It is also intended for testing of serum or plasma specimens to screen blood and/or plasma donors to exclude a history of syphilis.

FDA Enforcement
Class II ·Terminated·Clark Laboratories, Inc. (dba,Trinity Biotech USA)·January 1, 2014